FACULTY
Emerging Paradigms in the Management of Leukemias and Lymphomas
Based on proceedings from a roundtable symposium held in Orlando, Florida
Activity Date: May 2007  — Activity Info: Volume 7, (4)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 
Full Disclosure Policy Affecting CE Activities
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Directors and Participating Faculty reported the following:

PROGRAM DIRECTORS
Amy Hatfield, PharmD, BCOP
Clinical Specialist, Hematologic Malignancies
Department of Pharmacy
Sidney Kimmel Comprehensive Cancer Center
The Johns Hopkins Hospital
Baltimore, Maryland
Dr Hatfield reports having no significant financial or advisory relationships with corporate organizations related to this activity.

MiKaela Olsen, RN, MS
Oncology and Stem Cell TransplantClinical Nurse Specialist
Sidney Kimmel Comprehensive Cancer Center
The Johns Hopkins Hospital
Baltimore, Maryland
Ms Olsen reports serving on the speakers' bureau for Amgen Inc and Chiron.
PARTICIPATING FACULTY
Sandy Allen-Bard, RN, MSN, NPc
Leukemia Service
Weill Cornell Medical Center
New York, New York
Ms Allen-Bard reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Connie Zanzig Augustyniak, RN, BSN
Nurse Clinician
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois
Ms Augustyniak reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Deborah Blamble, PharmD, BCOP
Clinical Specialist, Leukemia
University of Texas
MD Anderson Cancer Center
Houston, Texas
Dr Blamble reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Chris Fausel, PharmD, BCOP
Clinical Pharmacist
Hematology/Oncology/BMT
Indiana University Cancer Center
Indianapolis, Indiana
Dr Fausel reports receiving honoraria from Amgen Inc.

Mollie Moran, MS, CNP
Nurse Practitioner/Hematologic Malignancies Program
Ohio State University
Arthur G. James Cancer Hospital
Columbus, Ohio
Ms Moran reports serving as a consultant for Berlex Oncology; and receiving honoraria for serving on the speakers' bureau for Genentech Biooncology and Novartis.

Amy Robbins, PharmD, BCOP
Clinical Specialist
Malignant Hematology/Stem Cell Transplant
Methodist Healthcare-University Hospital
Memphis, Tennessee
Dr Robbins reports having no significant financial or advisory relationships with corporate organizations related to this activity.
Notice: The following faculty member has disclosed that the article will reference unlabeled/unapproved drugs or products:

Dr Hatfield–5-azacytidine, arsenic, bortezomib, clofarabine, and decitabine.

All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

Johns Hopkins Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Johns Hopkins Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.
     
Home | Contact Us | View Account | Need Help?